Previous close | 0.0500 |
Open | 0.0640 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0500 - 0.0643 |
52-week range | 0.0500 - 0.0643 |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Amyris, Inc. (Nasdaq: AMRS) ("Amyris" or the "Company"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it is moving forward with an operational and financial restructuring to further advance its ongoing strategic transformation and position the Company for long-term success.
Ready to make sense of the market's laggards? The share prices of these high-octane growth stocks are falling in 2023, so it might be time to bet on rebounds -- but only some of them.
We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...